division of human gene therapy stanford university school of medicine stanford school of medicine human gene therapy in the department of pediatrics search this site only stanford medical sites ways to give find a person alumni lane library ways to give find a person department of pediatrics adolescent medicine cancer biology cardiology centers policy outcomes and prevention center for biomedical ethics bass center center of excellence in pulmonary biology wall center critical care endocrinology and diabetes gastroenterology general pediatrics human gene therapy hematology oncology and stem cell transplantation immunology and allergy infectious diseases medical genetics neonatal and developmental medicine nephrology pulmonary medicine rheumatology this requires the latest flash player human gene therapy developing gene transfer vectors human gene therapy targeting disease human gene therapy incorporating the latest research discoveries human gene therapy treating disease in the news feb 18 2007 rnai shows promise in gene therapy stanford researcher says more winter 2007 the promise of regenerative medicine more oct 4 2006 rnai research flourishing at school of medicine more more news about us the goal of the program in human gene therapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired diseases the general approach is to develop new vector systems and delivery methods test them in the appropriate animal models uncover the mechanisms involved in vector transduction and use the most promising approaches in clinical trials specifically we work on a variety of viral and non viral vector systems our major disease models are hemophilia hepatitis c and b viral infections and diabetes the second major focus includes the role that small rnas play in mammalian gene regulation rna to the rescue disease therapies based on a technique for gene silencing called rna interference are racing towards the clinic erika check investigates molecular medicine's next big thing more in the spotlight mark a kay md phd is the director of the program in human gene therapy and professor in the department of pediatrics and genetics at stanford university school of medicine dr kay is one of the founders of the american society of gene therapy and served as the president in 2005 2006 dr kay received the e mead johnson award for research in pediatrics in 2000 and was elected to the american society for clinical investigation in 1997 he has organized many national and international conferences including the first gordon conference related to gene therapy more you are here stanford medicine school of medicine departments pediatrics human gene therapy navigation for this section human gene therapy home education research faculty & staff contact us site navigation home education overview seminars research overview clinical trials related sites faculty faculty & staff contact us contact info maps & directions make a gift stanford medicine resources stanford medicine getting care overview find a physician find a clinical care center stanford hospital & clinics lucile packard children's hospital emergency research overview school of medicine news & resources clinical trials departments institutes & centers faculty profiles education & training overview school of medicine programs admissions continuing medical education alumni lane medical library community overview stanford health library community newsletter volunteering public service & community partnerships renewal & new building projects about us overview news careers ways to give find a person contact us maps & directions the dean's newsletter stanford university footer links contact us maps & directions how to help 2009 stanford school of medicine terms of use powered by irt
